Autolus Therapeutics (AUTL) Share-based Compensation (IS) (2018 - 2019)
Autolus Therapeutics posted quarterly Share-based Compensation (IS) of $16.2 million for Q2 2019, up 337.14% year-on-year from $3.7 million in Q2 2018, and up 337.14% on a QoQ basis from $3.7 million in Q2 2018.
Autolus Therapeutics (AUTL) has 2 years of Share-based Compensation (IS) data on file, last reported at $16.2 million in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 1.45 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 14.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | 16.23 Mn |
| Jun 30, 2019 | 16.23 Mn |
| Jun 30, 2018 | 3.71 Mn |
| Jun 30, 2018 | 3.71 Mn |